Table 4. Factors associated with CA-AKI and HA-AKI in hospitalized COVID patients, in the univariable and multivariable logistic regression model.
| Univariable analysis, OR (95% CI) | p | Multivariable analysis, OR (95% CI) | p | |
|---|---|---|---|---|
| Community-acquired AKI | ||||
| Grade COVID | ||||
| Mild | Reference | - | Reference | - |
| Severe | 1.15 (1.08–1.21) | <0.001 | 1.08 (1.02–1.14) | 0.005 |
| Diabetes | 1.18 (1.12–1.25) | <0.001 | 1.08 (1.02–1.15) | 0.005 |
| Hypertension | 1.22 (1.15–1.29) | <0.001 | 1.07 (1.00–1.14 | 0.02 |
| CKD | 1.56 (1.43–1.70) | <0.001 | 1.47 (1.35–1.60) | <0.001 |
| COPD | 1.24 (1.06–1.46) | 0.007 | 1.25 (1.07–1.45) | 0.003 |
| Serum Leukocytes > 12 [109/L] | 1.14 (1.07–1.21) | <0.001 | 1.10 (1.04–1.17) | <0.001 |
| Hospital-acquired AKI | ||||
| COVID severity | ||||
| Mild | Reference | - | Reference | - |
| Severe | 1.12 (1.07–1.18) | <0.001 | 1.13 (1.06–1.20) | <0.001 |
| Serum Ferritin > 500[ng/m] | 1.10 (1.04–1.16) | <0.001 | 1.07 (1.01–1.14) | 0.01 |
AKI, acute kidney injury; CA-AKI, community-acquired AKI; HA-AKI, hospital-acquired AKI; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease.